Searched for
PATHOLOGY LABS
These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 27%, according to analystsWe are in a phase in the US-Israel-Iran war where statements are made, then retracted. And, in a matter of just 48 hours, they are made all...- Infosys-backed 4baseCare raises Rs 128 crore, plans to take its cancer testing platform globalPrecision oncology startup 4baseCare has raised Rs 128 crore. This funding will expand its genomics labs globally and scale its AI platform...
- Max Healthcare Q4 results: Cons PAT grows 7% YoY to Rs 342 crore, revenue rises 12%Max Healthcare Q4FY26 consolidated PAT grew 7% YoY, and revenue increased 12%. Network EBITDA rose 8%. Max Lab and Max@Home saw strong doub...
- Open to 4-5 acquisitions, but at sensible valuations: Ameera Shah, promoter and executive chairperson, Metropolis HealthcareMetropolis Healthcare is set for its next growth phase. The diagnostic chain will focus on genomics and specialty diagnostics. Strategic ac...
- For investors with patience, experience, and anxiety appetite: 5 stocks from different sectors with upside potential of up to 21%For the last five years, the theme on the street has mostly been: Buy today, expect comfort tomorrow. But some of the better wealth-creatin...
- In 1928, Alexander Fleming Returned From Vacation: Found Mold in a Petri Dish and Discovered Penicillin, Changing Medicine ForeverA forgotten petri dish led to a groundbreaking discovery. Alexander Fleming observed mold inhibiting bacteria, a finding later developed in...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 29%In the current phase of market volatility, the only solace to be derived is from market history. And history tells us that, just like good ...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%It is tough to think positively about the markets when all the news is about blockades, wars, and everything that can disturb the global ec...
- Anthropic acquires Coefficient Bio for nearly $400 million: ReportAnthropic acquires startup Coefficient Bio for about $400 million: report
- Maharashtra government to bring new law to crack down on bogus pathology labsThe issue concerns the urban development, public health and medical education departments, Samant said. BJP MLA Ashish Shelar said bogus pa...
- HC asks Delhi government to comply with order to regulate online path labs or face actionThe plea alleged non-compliance of the high court's August 6, 2020 order to take action against illegal online health service aggregators o...
- Plea in HC for urgent implementation of Delhi Health Bill to regulate illegal pathological labsThe application by consumer rights activist Bejon Kumar Misra has contended that operations of illegal and unauthorised labs would endanger...
- Metropolis acquires Sanjeevani Pathology Labs in an all-cash transactionMetropolis has adopted a string of pearls strategy by either partnering or acquiring smaller brands in newer markets.
- J P Nadda asks Delhi government to implement law to regulate private clinicsExpressing concern over growing number of unregulated pathological labs and clinics, Health Minister J P Nadda urged the Delhi government.
- Delhi HC reserves verdict on PIL against illegal labs in residential areasThe petition by NGO Paardarshita has alleged that there is a large number of unauthorised pathological labs in various residential areas of...
- Supreme Court orders closure of path lab in Delhi's residential areaApex court said that both MCD and DPCC "abdicated" their statutory duties in permitting the owners to carry on with the unlawful activities.
- Medizinisch Diagnostiche Institute to invest Rs 50 cr in Indian armLargest German clinical laboratory, the Medizinisch Diagnostiche Institute (MDI), proposes to invest Rs 50 crore in its Indian subsidiary.
- Neon Healthcare ties with US based Hayes LabNeon Healthcare and Research Institute Ltd has signed an agreement with US-based pathological lab Hayes Lab for outsourcing in the healthca...
- Wellspring buys out 40% in Phadke JVThe entity will be renamed as Wellspring-Dr Avinash Phadke Pathlab and Diagnostics. This will make Wellspring India’s largest pathology lab...
- Ranbaxy is eyeing buyouts in pathology labs businessSRL Ranbaxy is aggressively eyeing acquisitions in the pathology lab business. The pathology testing business of Ranbaxy group has formed a...
Load More
